Price Target Estimates for Bristol-Myers Squibb Company (BMY)

Adjust Comment Print

There are brokerage firms with lower targets than the average, including one setting a price target of $17. Barclays Capital maintained W W Grainger Inc (NYSE:GWW) rating on Monday, October 19. Morgan Stanley maintained Equifax Inc. As per Friday, December 18, the company rating was initiated by Atlantic Securities. The stock of Equifax Inc. The firm has "Underperform" rating by Credit Suisse given on Wednesday, April 19. Goldman Sachs Group, Inc. With 2.59M avg volume, 3 days are for Carnival Corporation (NYSE:CCL)'s short sellers to cover CCL's short positions. Proficio Capital Partners LLC now owns 2,204 shares of the biopharmaceutical company's stock worth $119,000 after buying an additional 504 shares during the last quarter. On Monday, November 9 the stock rating was maintained by TH Capital with "Buy".

Bristol-Myers Squibb Company (BMY) knifed -1.82 percent lower and now trades for $60.86. On October 26, 2017 BMO Capital Markets issued a report on BMY and giving a rating of "Sell" and projecting a price target of $49.00. Jacobs And Company Ca holds 64,100 shares.

The market capitalization of Bristol-Myers Squibb Company is at $101.46 Billion.


Analysts look for public financial statements, listen in on conference calls and talk to managers and customers of a company in order to reach an opinion and communicate the value of a stock.

Bristol-Myers Squibb Company (NYSE:BMY), maintained return on investment for the last twelve months at 17.16, higher than what Reuters data shows regarding industry's average. It has underperformed by 39.89% the S&P500. Investors of record on Friday, October 6th were issued a dividend of $0.39 per share. Its down 0.32, from 1.12 in 2017Q1.

Institutional investors and hedge funds have recently bought and sold shares of the company. 120 funds opened positions while 451 raised stakes. Cetera Advsr Limited Liability Co has 7,048 shares. The original version of this news story can be read at https://www.truebluetribune.com/2017/11/13/bristol-myers-squibb-company-bmy-rating-lowered-to-hold-at-zacks-investment-research.html. Delta Asset Mngmt Tn accumulated 68,741 shares. Envestnet Asset Management invested in 81,363 shares or 0.01% of the stock. The company's revenue for the quarter was up 6.7% compared to the same quarter last year. equities research analysts predict that Bristol-Myers Squibb will post 2.99 earnings per share for the current fiscal year. Suntrust Banks Incorporated has 706,454 shares. The Price to Sales (P/S) ratio of the stock is 4.84, while P/B (Price to Book) stands at 6.75. Halsey Associates Incorporated Ct invested in 0.06% or 5,670 shares. 82,386 are held by Tudor Corporation Et Al. After $0.75 actual earnings per share reported by Bristol-Myers Squibb Co for the previous quarter, Wall Street now forecasts -10.67% negative EPS growth. Regions Financial owns 3,760 shares for 0.01% of their portfolio. The stock rose 0.38% or $0.23 reaching $61.09. Artemis Investment Management Llp reported 158,000 shares.


Bristol-Myers Squibb Company (NYSE:BMY) traded at an unexpectedly low level on 10/11/2017 when the stock experienced a -1.82% loss to a closing price of $60.86. To make a proper assessment, investors seek a sound estimate of this year's and next year's earnings per share (EPS), as well as a strong sense of how much the company will earn even farther down the road. BMY's profit will be $1.10 billion for 22.63 P/E if the $0.67 EPS becomes a reality. First New York Securities LLC NY bought a new stake in shares of Bristol-Myers Squibb during the third quarter valued at about $108,000.

The consensus recommendation - averaging the work of 22 analysts - of 2.5 for Bristol-Myers Squibb Company (BMY) points to moderate case. Therefore 12% are positive. The average analysts gave this company a mean recommendation of 2.50. Hilliard Lyons downgraded the shares of BMY in report on Tuesday, September 12 to "Hold" rating. Deutsche Bank maintained the shares of BMY in report on Friday, October 28 with "Hold" rating. Cowen & Co maintained the stock with "Hold" rating in Monday, September 18 report. The stock has "Outperform" rating by RBC Capital Markets on Tuesday, October 11. The firm earned "Hold" rating on Thursday, July 27 by Piper Jaffray. The rating was maintained by RBC Capital Markets on Wednesday, April 12 with "Sell". Western Gas Partners, LP (NYSE:WES) has risen 10.32% since November 13, 2016 and is uptrending. It has underperformed by 5.42% the S&P500. Its down 0.03, from 1.15 in 2017Q1. 69 funds opened positions while 216 raised stakes. Congress Asset Mngmt Ma reported 0.01% stake. Gotham Asset Ltd Llc reported 185,809 shares or 0.47% of all its holdings. Tcw Gp Inc has invested 0.01% in Reynolds American, Inc. Buckingham Asset Mngmt Limited Liability Company has invested 0.23% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Amica Retiree Medical Tru holds 0.45% or 9,944 shares. Bnp Paribas Asset Holding stated it has 0.65% of its portfolio in Reynolds American, Inc. (NYSE:EFX). Sabal Communications accumulated 4,680 shares. Harding Loevner Lp holds 0% in Equifax Inc. (NYSE:RAI). Invsts invested in 30.35 million shares. Moreover, Insight Research & Mgmt Inc has 1.12% invested in Carnival Corp (NYSE:CCL). Royal National Bank Of Canada holds 0.13% in Bristol-Myers Squibb Co (NYSE:BMY) or 4.68 million shares. Piedmont Invest Advsrs reported 188,775 shares. As of the end of the quarter Farr Miller & Washington LLC/dc had acquired a total of 324,976 shares growing its stake by 573.5%. It helps investors in determining whether buying, selling or holding on to a stock would be beneficial for them. Bnp Paribas Arbitrage Sa accumulated 1.89 million shares or 0.32% of the stock.


Comments